Figure 10 — Identifying competing endogenous RNA regulatory networks and hub genes in alcoholic liver disease for early diagnosis and potential therapeutic target insights

Research Paper|Volume 16, Issue 10|pp. 9147–9167

Identifying competing endogenous RNA regulatory networks and hub genes in alcoholic liver disease for early diagnosis and potential therapeutic target insights

Back to articleFigure 10(10 of 11)

100%

Figure 10.The immunohistochemistry staining of protein in human liver tissue, as sourced from the Human Protein Atlas version 23.0. (A) The immunohistochemical staining of the TP53 protein in the liver tissue of patients with liver cancer (Tumor#3334) is available from https://images.proteinatlas.org/39238/82313_B_7_4.jpg. The immunohistochemical staining of the TP53 protein in normal liver tissue (Normal#1720) is available from https://images.proteinatlas.org/2973/6986_A_8_4.jpg. (B) The immunohistochemical staining of the TCP1 protein in the liver tissue of patients with liver cancer (Tumor#2177) is available from https://images.proteinatlas.org/17460/45305_B_8_1.jpg. The immunohistochemical staining of the TCP1 protein in normal liver tissue (Normal#3402) is available from https://images.proteinatlas.org/27337/59054_A_7_4.jpg. (C) The immunohistochemical staining of the VCL protein in the liver tissue of patients with liver cancer (Tumor#1287) is available from https://images.proteinatlas.org/2131/7208_B_8_1.jpg. The immunohistochemical staining of the VCL protein in normal liver tissue (Normal#1846) is available from https://images.proteinatlas.org/2131/7209_A_8_4.jpg. (D) The immunohistochemical staining of the ANXA2 protein in the liver tissue of patients with liver cancer (Tumor#1163) is available from https://images.proteinatlas.org/4311/13252_B_8_5.jpg. The immunohistochemical staining of the ANXA2 protein in normal liver tissue (Normal#3222) is available from https://images.proteinatlas.org/46964/138243_A_9_4.jpg. (E) The immunohistochemical staining of the SPARC protein in the liver tissue of patients with liver cancer (Tumor#2325) is available from https://images.proteinatlas.org/2306/6035_B_8_6.jpg. The immunohistochemical staining of the SPARC protein in normal liver tissue (Normal#1846) is available from https://images.proteinatlas.org/2989/9780_A_7_4.jpg. (F) The immunohistochemical staining of the CD86 protein in the liver tissue of patients with liver cancer (Tumor#1022) is available from https://images.proteinatlas.org/4319/11662_B_8_2.jpg. The immunohistochemical staining of the CD86 protein in normal liver tissue (Normal#1899) is available from https://images.proteinatlas.org/4319/11663_A_9_4.jpg. (G) The immunohistochemical staining of the ROCK1 protein in the liver tissue of patients with liver cancer (Tumor#2279) is available from https://images.proteinatlas.org/7567/21572_B_7_1.jpg. The immunohistochemical staining of the ROCK1 protein in normal liver tissue (Normal#2429) is available from https://images.proteinatlas.org/7567/21573_A_8_4.jpg. (H) The immunohistochemical staining of the KLRD1 protein in the liver tissue of patients with liver cancer (Tumor#5192) is available from https://images.proteinatlas.org/69688/153609_B_7_1.jpg. The immunohistochemical staining of the KLRD1 protein in normal liver tissue (Normal#1720) is available from https://images.proteinatlas.org/69688/153740_A_8_4.jpg. (I) The immunohistochemical staining of the TUBA1A protein in the liver tissue of patients with liver cancer (Tumor#952) is available from https://images.proteinatlas.org/8686/23064_B_9_7.jpg. The immunohistochemical staining of the TUBA1A protein in normal liver tissue (Normal#3402) is available from https://images.proteinatlas.org/43684/102076_A_7_4.jpg.